Jakarta (ANTARA) - PT Kalbe Farram Tbk (KLBF) is considering the\npossibility of delisting its subsidiary, PT Enseval Putera Megatrading\nTbk (EPMT), if efforts to increase the company\u2019s public share portion\n(free float) prove difficult under the new regulations set by the\nIndonesia Stock Exchange (IDX).<\/p>\n
Kalbe Farma Director Kartika Setiabudy acknowledged that the free\nfloat of one of its subsidiaries does not yet meet the new requirements\nestablished by the IDX, prompting the company to review several options\nto ensure compliance with capital market regulations.<\/p>\n
\u201cIt is true that one of our subsidiaries currently does not meet the\nnew free float requirements requested by the IDX,\u201d Kartika stated during\na Public Expose Live event in Jakarta on Friday.<\/p>\n
Kartika revealed that the company is currently conducting internal\ncalculations while exploring the possibility of obtaining additional\nfree float from external sources. This approach is the primary option\nbeing considered, as increasing public ownership must be carried out\ngradually in accordance with IDX regulations, specifically in 2027 and\n2028.<\/p>\n
However, if increasing the free float is deemed difficult to achieve,\nKalbe Farma does not rule out corporate action in the form of delisting\nEPMT. \u201cAt the same time, we are also exploring the potential for\ndelisting should the increase in free float prove difficult to\nimplement,\u201d said Kartika.<\/p>\n
She continued, noting that no final decision has been made regarding\neither option, as both increasing the free float and delisting are still\nin the exploration and calculation stages. She ensured that all options\npursued will consider IDX regulations and the established deadlines.<\/p>\n
\u201cTherefore, we are currently exploring these options to comply with\nIDX regulations, as we are part of the Indonesian capital market,\u201d said\nKartika.<\/p>\n
Furthermore, Kartika stated that the company is open to input from\nmarket participants to determine the most appropriate course of action\nto meet these requirements. \u201cWe also remain open to market feedback\nregarding the options we must explore and implement in accordance with\nthe expected timeline,\u201d added Kartika.<\/p>\n
EPMT is a company engaged in the distribution and trading of health\nproducts and is a subsidiary of Kalbe Farma. Currently, EPMT\u2019s free\nfloat stands at approximately 7.53 per cent, with PT Kalbe Farma Tbk\n(KLBF) as the majority shareholder with 92.47 per cent.<\/p>\n
Meanwhile, the IDX has mandated that listed companies must increase\nand meet a minimum free float of 12.5 per cent by 31 March 2027, and\nsubsequently must reach 15 per cent by 31 March 2028.<\/p>", "url": "https:\/\/jawawa.id\/newsitem\/kalbe-farma-considers-delisting-epmt-if-free-float-requirements-cannot-be-met-1789103498", "image": "" }, "sponsor": "Okusi Associates", "sponsor_url": "https:\/\/okusiassociates.com" }